| Seroconversion status (≥ fourfold increase in Ab titres) |  | |||
---|---|---|---|---|---|
Vaccine strain | Young cohort (n = 58) | Older cohort (n = 54) | p | ||
 | Placebo | B. longum + Gl-OS | Placebo | B. longum + Gl-OS |  |
 | n/N (%) | n/N (%) | n/N (%) | n/N (%) |  |
A/California/7/2009 (H1N1) | 15/29 (52) | 18/29 (62) | 21/27 (78) | 15/26 (58) | NS |
A/Perth/16/2009 (H3N2) | 20/29 (69) | 22/29 (76)a | 17/27 (63) | 10/26 (38) | 0.031 |
B/Brisbane/60/2008 | 23/29 (79)a | 20/29 (69)a | 7/27 (26) | 1/26 (4) | < 0.001 |